A significant proportion of overweight or obese patients don’t find pharmaceutical ads about weight-management products relatable, nor do they look to those ads for information about managing their ...

The Association of American Medical Colleges is planning to roll out new standards aimed at teaching physicians how to treat patients who are overweight in an equitable manner, reported NBC News May ...

A Wegovy trial found those taking the weight loss injections had a 20% cut in the risk of major heart problems including ...

Researchers at the University of Cincinnati studying data from common oral surgeries have found that patients with higher body mass index (BMI) are more difficult to sedate and more prone to ...

A new paper in Family Practice, published by Oxford University Press, indicates that overweight patients are more inclined to disagree with their healthcare providers on advice on weight loss and ...

Add Yahoo as a preferred source to see more of our stories on Google. The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of ...

BOSTON - Patients who are overweight when they're first diagnosed with cancer may be at higher risk of developing a second cancer. Investigators at the American Cancer Society looked at data on nearly ...

Glucagon-like peptide-1 (GLP-1) receptor agonists provide similar reductions in major adverse cardiovascular events, all-cause death, and cardiovascular-related death in patients with overweight and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In the United States, just half of patients with type 1 ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved an expanded label for semaglutide 2.4 mg for prevention of CV events in patients with ...